Comparison of Allogeneic Platelet-rich Plasma With Autologous Platelet-rich Plasma for the Treatment of Diabetic Lower Extremity Ulcers

Cell Transplant. 2020 Jan-Dec:29:963689720931428. doi: 10.1177/0963689720931428.

Min He^{1

2

3}, Xuewen Guo^{1

4

3}, Tao Li^{1

2

3}, Xiaoyan Jiang¹, Yan Chen¹, Yi Yuan¹, Bing Chen², Gangyi Yang⁴, Yahan Fan⁵, Ziwen Liang², David G Armstrong⁶, Wuquan Deng¹

¹ Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, China.
² Department of Endocrinology, Chongqing Southwest Hospital, China.
³ These authors contributed equally to this article.
⁴ Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, China.
⁵ Department of Blood Transfusion, Southwest Hospital, Chongqing, China.
⁶ Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, USA.

Abstract

ChiCTR1900021317.

Keywords: allogeneic platelet-rich plasma; autologous platelet-rich plasma; diabetic foot ulcers; diabetic lower extremity ulcers.